[SCHEDULE 13G/A] Neuronetics, Inc. Amended Passive Investment Disclosure
Rhea-AI Filing Summary
Neuronetics, Inc. filing amends beneficial ownership disclosure for Jorey Chernett. As of the close of business on
The amendment updates the Schedule 13G/A ownership figures and reports sole voting and dispositive power over the disclosed shares. The statement is signed and dated
Positive
- None.
Negative
- None.
Insights
Disclosure clarifies a >10% stake by an individual investor.
The filing documents that Jorey Chernett beneficially owns 7,516,404 shares, equal to 10.85% of outstanding common stock using the issuer's stated outstanding share count of 69,276,593 as of March 10, 2026. This meets the Schedule 13G/A threshold for beneficial owner reporting.
The primary dependency is the issuer's outstanding share count cited from the Form S-3; any future updates to outstanding shares would change the percent calculation. Subsequent filings could adjust ownership percentages if shares are acquired or disposed.